Physician profile
Joanna E Khatib
NPI 1306227400
$6,844.52
in general payments reported to CMS, 2019-2025
44 companies · $937 in 2025
The $937 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $208 · 2021: $1,708 · 2022: $710 · 2023: $974 · 2024: $1,067 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,019.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $478.90 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $467.44 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $378.84 | 2021-2025 | Repatha, Repatha, Tepezza |
| Abbvie INC. | $365.16 | 2020-2025 | |
| Pfizer INC. | $283.84 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $277.88 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Dexcom, INC. | $259.08 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $240.87 | 2021-2024 | |
| Radius Health, INC. | $182.11 | 2023-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.08 | 2022-2025 | Jardiance |
| Daiichi Sankyo INC. | $163.43 | 2020-2022 | |
| Recordati_rare_diseases_inc. | $124.98 | 2021-2024 | Signifor Lar, Isturisa |
| Corcept Therapeutics | $124.82 | 2021-2025 | Korlym |
| Insulet Corporation | $116.02 | 2023-2025 | Omnipod |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Khatib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.